SBRT vs 20-fraction RT for any-risk prostate cancer: ePRO-measured acute toxicity in a randomised trial (OPTIMAL)

Thilo Schuler MD

Radiation Oncology Doctor

My research revolves around Digital Health with a focus on patient-generated data and routine care translation. In particular I am interested in digitally-enhanced approaches in GU and palliative Radiation Oncology and more broadly in improving interdisciplinary support of cancer patients.